Suzanne S. Mirra, MD
Affiliations: | Pathology | State University of New York, Cortland, NY, United States |
Area:
basic and clinical science aspects of Alzheimer’s disease and other neurodegenerative disorders.Website:
http://www.downstate.edu/pathology/Dr.SuzanneS.MirraMD.htmGoogle:
"Suzanne Mirra"Bio:
2005 Award for Meritorious Contributions to Neuropathology
2000 AANP President
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=118
Cross-listing: Neurotree - Alzheimer's Tree
Children
Sign in to add traineeJohn F. Crary | grad student | 2006 | State University of New York Health Science Center at Brooklyn (Neurotree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Hernández AI, Oxberry WC, Crary JF, et al. (2014) Cellular and subcellular localization of PKMζ. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 369: 20130140 |
Hyman BT, Phelps CH, Beach TG, et al. (2012) National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 1-13 |
Montine TJ, Phelps CH, Beach TG, et al. (2012) National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathologica. 123: 1-11 |
Shao CY, Mirra SS, Sait HB, et al. (2011) Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer's disease. Acta Neuropathologica. 122: 285-92 |
Shao CY, Nes PVD, Rajamohamedsait HB, et al. (2010) The postsynaptic density protein, PSD-95, coexists with neuropathological changes in 5XFAD and P301L transgenic mice Alzheimers & Dementia. 6 |
Fillenbaum GG, van Belle G, Morris JC, et al. (2008) Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: 96-109 |
Schweitzer K, Decker E, Zhu L, et al. (2006) Aberrantly regulated proteins in frontotemporal dementia. Biochemical and Biophysical Research Communications. 348: 465-72 |
Shiarli AM, Jennings R, Shi J, et al. (2006) Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease. Neuropathology and Applied Neurobiology. 32: 374-87 |
Shao CY, Crary JF, Rao C, et al. (2006) Atypical protein kinase C in neurodegenerative disease II: PKCiota/lambda in tauopathies and alpha-synucleinopathies. Journal of Neuropathology and Experimental Neurology. 65: 327-35 |
Crary JF, Shao CY, Mirra SS, et al. (2006) Atypical protein kinase C in neurodegenerative disease I: PKMzeta aggregates with limbic neurofibrillary tangles and AMPA receptors in Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 65: 319-26 |